eli lilly retatrutide trial Lilly's Next-Gen Obesity Drug Delivers Positive Weight-Loss Results eli lily retatrutide Lilly's tirzepatide

WEIGHT-LOSS DRUGS' IMPACT ON CANCER RISK REVEALED IN NEW STUDY The National Institutes of Health (NIH) published research in June 2024 that considered the correlation between semaglutide therapy and "exacerbating mood disturbances." The study highlighted the association of negative mood changes in patients with type 2 diabetes with a history of depression, warning healthcare providers to be aware of this "potential risk." But a more recent study, published in the journal Diabetes, Obesity and Metabolism, suggested that these mood changes were linked to genetic variations across diverse populations and ancestries within the U.K

More protein drinks, taste tested and approved by editors A thinner yogurt option: Average mouthfeel score: 4.17/5 | Average texture/consistency score: 4.33/5 | Average flavor score: 4.33/5 | Overall average score: 4.28/5 Oikos came in at a very close second to Chobani, only because it had a bit more of a sour flavor and a thinner consistency that most testers didnt prefer over Chobanis sweeter flavor (though one tester really liked the sourness and thinner consistency of this one)

Store it frozen at -20C (-4F) for long-term storage, where it remains viable for years

The most clinically serious rare side effects are acute pancreatitis, gallbladder disease, and severe allergic reactions

If your hunger is very low and youre struggling to eat your meals, eat the protein portion first

Community sources variously attribute it to dose, to the DMSO carrier in transdermal use, or to vascular effects, with no way to confirm cause in self-reports